1 study found for:    24316262 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
Conditions: Genotype 1 Chronic Hepatitis C;   Treatment Naive
Interventions: Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated interferon alfa-2a

Indicates status has not been verified in more than two years